Validation and data quality play a major role in modern life science. Legal validation, patents, and clinical testing have become crucial issues. Automation enables a much higher reproducibility and better documentation of data. This allows the production of more data points with great ease. It also ensures the safety of personnel in the presence of infectious or potentially hazardous material.
Automation is used in a wide variety of life science applications ranging from proteomics to systems biology. Automation is a dominant feature in the diagnostics market followed by the discovery and research labs. In clinical diagnostics, where profits are based on the number of samples, high throughput is the core driving factor. Total automation is generally preferred in such labs and manufacturing setups. Research labs and academic institutions are generally opting for modular automation, wherein they reduce the human intervention in tedious and repetitive tasks.
Place Direct Purchase Order of this Report: http:// www. orbisresearch. com / contact / purchase / 223734
North America is clearly the market leader with a total market share of 60 %, followed by Europe. Asia and Latin America are emerging as there has been a considerable increase in outsourcing pharmaceutical manufacturing to these regions due to the availability of cheaper labor and resources.
This report analyzes the market across various geographies with the key trends in each region. It provides the market share and profiles of the top companies involved in lab automation. The report also provides insights on how the market will vary within the next five years.
DRIVERS: 1. Advancement in plastic molding technology 2. Development of smaller automated machines 3. Need for higher reproducibility and effective management of the vast amounts of data generated
RESTRAINTS: 1. Initial setup is expensive 2. Loss of flexibility in process 3. Interconnecting various platforms across the lab
3